Access to Earth's freshwater reserves is alarmingly limited, with less than 1% readily
available. Factors such as industrialisation, population expansion, and climate change …

An up-to-date pooled case fatality rate (CFR) for Ebola disease (EBOD) at the global level is
lacking. We abstracted EBOD data from 1976 to 2022 for 16 countries and 42 outbreaks to …

Background Rapid diagnosis and treatment has improved outcome of patients with vaccine-
induced immune thrombocytopenia and thrombosis (VITT). However, after the acute …

Electrical stimulation (ES) has emerged as a powerful therapeutic modality for enhancing
biological wound healing. This non-invasive technique utilizes low-level electrical currents …

Adenoviral vectors are crucial for gene therapy and vaccine development, offering a platform
for gene delivery into host cells. Since the discovery of adenoviruses, first-generation vectors …

Ebola virus disease (EVD) is a severe and highly fatal zoonotic disease caused by viruses in
the family Filoviridae and genus Ebolavirus. The disease first appeared in Zaire near the …

With two endorsed and prophylactic vaccines against Zaire ebolavirus (referred to hereafter
as EBOV), the number of individuals vaccinated against EBOV worldwide is estimated to …

Micro/nano-robots (MNR) have gained attention as a rapidly develo** field with significant
potential in advanced therapies and futuristic solutions. These self-propelled robots offer a …

Vesicular stomatitis virus (VSV) represents a significant advancement in therapeutic
medicine, offering unique molecular and cellular characteristics that make it exceptionally …

Vaccines signify one of the economical and reasonable means to prevent and eradicate the
important infectious diseases. Conventional vaccines like live attenuated and inactivated …